Introduction
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Infectious diseases (e.g. tuberculosis and pneumonia) were the leading cause of death To confirm the MALDI-TOF results that characterized the clinical isolate as C. gattii, the 2 1 0
isolate was subjected to a number of phenotypic tests. The isolate was grown on media to test
for growth (YPD), melanin production (Niger Seed), urease production (Christensen's Agar), Cryptococcus species ( Figure 3A ). The isolate grew and produced blue pigment on CGB agar
which is unique to C. gattii species ( Figure 3A ) (30). Cryptococcus produces a hydrophilic production, India ink staining and microscopic evaluation was performed after growth in CO 2 -
independent medium for 72 hours at 37°C. Using the C. deuterogattii reference strain R265 for
comparison, the patient isolate produced similar capsules ( Figure 3B ).
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As previously mentioned, the majority of isolates characterized in C. gattii are of the indicating the isolate is of the α mating-type ( Figure 3C ). No self-sporulation was observed when
the patient isolate was incubated alone on mating media providing evidence that the isolate is
not an a-α diploid or self-fertile (Supplemental Figure 2 ). MLST analysis was performed to assign the clinical isolate to a species within the C.
gattii species complex. MLST loci were PCR amplified with primers designed to amplify each
sequence, the PCR products were purified, analyzed by Sanger sequencing, and the 2 3 2 sequences were assembled in Sequencher using forward and reverse strands to ensure 2 3 3 complete double-stranded coverage. Phylogenetic analysis was performed using representative
sequences from each of the C. gatti molecular types: A lineage of C. deuterogattii VGIIa-like isolates was previously described that display a Interestingly, the patient did have high titer anti-GM-CSF autoantibodies in the blood, of macrophage function, a cell type important for the control of cryptococcal infection.
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Specifically, these antibodies block STAT5 phosphorylation, which inhibits macrophage but to a much lesser degree than those with cryptococcal infection and autoantibodies (10).
4 7
Because screening for anti-GM-CSF autoantibodies is not routinely performed in healthy Methenamine Silver (GMS) staining was performed at 20X and 60X magnification using formalin-fixed, paraffin-embedded tissue. The control strain R265 and the clinical isolate SEC744 were inoculated into liquid YPD (1% 
